|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 2.040 SEK | -1.45% |
|
+0.99% | +7.37% |
| 09-02 | Enzymatica CEO buys additional shares | FW |
| 09-01 | Enzymatica CEO buys 33 384 shares | FW |
Company Valuation: Enzymatica AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 2,671 | 1,305 | 739.2 | 648 | 340.9 | 461.2 |
| Change | - | -51.13% | -43.36% | -12.33% | -47.39% | 35.28% |
| Enterprise Value (EV) 1 | 2,662 | 1,276 | 710.8 | 657.7 | 267.9 | 429.1 |
| Change | - | -52.06% | -44.3% | -7.47% | -59.27% | 60.16% |
| P/E | -202x | -28.2x | -10.1x | -13x | -5.73x | -8.89x |
| PBR | 25x | 10.4x | 5.85x | 8.46x | 2.17x | 3.71x |
| PEG | - | -0x | -0.2x | 0.4x | 0.65x | 0.4x |
| Capitalization / Revenue | 24x | 22.8x | 15.1x | 12.7x | 7.48x | 8.56x |
| EV / Revenue | 23.9x | 22.3x | 14.5x | 12.9x | 5.88x | 7.96x |
| EV / EBITDA | -292x | -29.6x | -10.9x | -14.6x | -5.44x | -8.79x |
| EV / EBIT | -221x | -28.2x | -10.4x | -13.7x | -5.15x | -8.35x |
| EV / FCF | -302x | -50.8x | -16.2x | -40.1x | -5.45x | -19.5x |
| FCF Yield | -0.33% | -1.97% | -6.17% | -2.49% | -18.3% | -5.12% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0926 | -0.3096 | -0.445 | -0.3027 | -0.2759 | -0.2138 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 111.2 | 57.24 | 48.95 | 50.9 | 45.58 | 53.9 |
| EBITDA 1 | -9.122 | -43.1 | -65.08 | -44.96 | -49.22 | -48.83 |
| EBIT 1 | -12.06 | -45.25 | -68.22 | -48.06 | -52.05 | -51.37 |
| Net income 1 | -13.22 | -45.39 | -68.66 | -49.73 | -53.18 | -51.89 |
| Net Debt 1 | -9.165 | -28.98 | -28.37 | 9.712 | -73.01 | -32.11 |
| Reference price 2 | 18.700 | 8.740 | 4.500 | 3.945 | 1.580 | 1.900 |
| Nbr of stocks (in thousands) | 142,824 | 149,324 | 164,257 | 164,257 | 215,769 | 242,735 |
| Announcement Date | 3/31/21 | 3/31/22 | 4/5/23 | 4/9/24 | 4/10/25 | 4/14/26 |
1SEK in Million2SEK
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 51.11M | |
| 31.77x | 11.54x | 23.41x | 0.62% | 994B | |
| 29.54x | - | - | 2.02% | 640B | |
| 32.92x | 7.63x | 15.78x | 2.67% | 454B | |
| 18.71x | 4.57x | 11.31x | 2.91% | 337B | |
| 19.41x | 5.08x | 12.59x | 3.21% | 261B | |
| 20.34x | 4.19x | 11.96x | 2.11% | 246B | |
| 23.87x | 6.3x | 11.23x | 2.67% | 204B | |
| 12.3x | 4.48x | 9.37x | 4.08% | 190B | |
| -43.47x | 6.35x | 24.81x | 2.29% | 178B | |
| Average | 16.16x | 6.27x | 15.06x | 2.51% | 350.48B | |
| Weighted average by Cap. | 23.19x | 7.72x | 17.10x | 2.05% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ENZY Stock
- Valuation Enzymatica AB
Select your edition
All financial news and data tailored to specific country editions
